Table 1. Comparison of haloduracin and nisin activities.
Specific activity of haloduracin and nisin assessed by liquid growth inhibition assay | |||||
---|---|---|---|---|---|
Haloduracin |
Nisin |
||||
Strain | Source | IC50 (nM) | MIC (nM) | IC50 (nM) | MIC (nM) |
Lactococcus lactis HP | ATCCa 11602 | 29 ± 21 | 73.4 | 14 ± 5 | 32.2 |
Lactococcus lactis 481 | CNRZb 481 | 63 ± 24 | 195 | 68 ± 6 | 127 |
Lactococcus lactis 11454 | ATCC 11454 | 308 ± 13 | 625 | 1,759 ± 400 | 2,800 |
Vancomycin-resistant Enterococcus faecium | C33105c | 265 ± 15 | 781 | 4,953 ± 187 | 12,500 |
Bacillus anthracis Sterne 7702 | Gut et al.d | 363 ± 54 | 677 | 311 ± 216 | 417 |
Bacillus subtilis | ATCC 6633 | 262 ± 54 | 469 | 414 ± 165 | 820 |
methicillin-resistant Staphylococcus aureus | C5c | 2,616 ± 396 | 4,690 | 1,459 ± 7 | 1,560 |
Staphylococcus aureus | ATCC 12600 | 1,144 ± 290 | 1,560 | 2,205 ± 523 | 4,690 |
Staphylococcus epidermidis 15X | Ekkelenkamp et al.e | 273 ± 23 | 313 | 368 ± 152 | 508 |
Micrococcus luteus | ATCC 4698 | 520 ± 17 | 1,250 | 266 ± 92 | 410 |
Streptococcus mutans | ATCC 25175 | 1,837 ± 417 | 2,500 | 5,394 ± 732 | 12,500 |
Activity assessed by agar diffusion growth inhibition assay | |||
---|---|---|---|
Strain | Source | Haloduracin | Nisin |
Lactococcus lactis 117 | CNRZ 117 | + | + |
Bacillus subtilis DB104 | Kawamura et al.f | + | + |
Bacillus subtilis LH45 | Liu et al.g | + | + |
Bacillus cereus Z4222 | INRAh Z4222 | + | + |
Bacillus cereus TZ415 | INRA TZ415 | + | + |
Enterobacter cloacae 10-19C | ATCC 29893 | − | − |
Escherichia coli DH5α | UIUC-CMFi | − | − |
ATCC: American type Culture Collection.
CNRZ: National Centre for Zootechnical Research.
Clinical isolates from Carle Foundation Hospital (Urbana, IL).
Reference (17).
Reference (43).
Reference (44).
Reference (45).
INRA: Institut National de la Recherche Agronomique.
UIUC-CMF: University of Illinois Urbana-Champaign Cell and Media Facility.